Hypoxic Induction of Vasorin Regulates Notch1 Turnover to Maintain Glioma Stem-like Cells.

[1]  Shawn M. Gillespie,et al.  Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance. , 2017, Cell stem cell.

[2]  R. Verhaak,et al.  GlioVis data portal for visualization and analysis of brain tumor expression datasets. , 2017, Neuro-oncology.

[3]  Steven J. M. Jones,et al.  Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma , 2016, Cell.

[4]  L. Mariani,et al.  A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes. , 2015, Cancer cell.

[5]  Alexander R. Pico,et al.  Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. , 2015, The New England journal of medicine.

[6]  Jennifer S. Yu,et al.  Sema3C promotes the survival and tumorigenicity of glioma stem cells through Rac1 activation. , 2014, Cell reports.

[7]  A. Meunier,et al.  NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer , 2014, Nature Reviews Urology.

[8]  Shawn M. Gillespie,et al.  Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.

[9]  Emma R. Andersson,et al.  Therapeutic modulation of Notch signalling — are we there yet? , 2014, Nature Reviews Drug Discovery.

[10]  M. Pawlus,et al.  STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells , 2014, Oncogene.

[11]  J. Huse,et al.  Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth. , 2014, Cell stem cell.

[12]  Cheng-Jun Hu,et al.  STAT3 or USF2 Contributes to HIF Target Gene Specificity , 2013, PloS one.

[13]  R. McLendon,et al.  Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth , 2013, Cell.

[14]  C. Brou,et al.  Ubiquitinations in the Notch Signaling Pathway , 2013, International journal of molecular sciences.

[15]  David Haussler,et al.  ENCODE Data in the UCSC Genome Browser: year 5 update , 2012, Nucleic Acids Res..

[16]  F. Roegiers,et al.  Endocytosis and control of Notch signaling. , 2012, Current opinion in cell biology.

[17]  R. Hu,et al.  HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway , 2011, Cell Death and Differentiation.

[18]  Tzong-Shiue Yu,et al.  A restricted cell population propagates glioblastoma growth after chemotherapy , 2012 .

[19]  F. DiMeco,et al.  Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. , 2011, Cancer research.

[20]  C. Deng,et al.  A HIF-1 target, ATIA, protects cells from apoptosis by modulating the mitochondrial thioredoxin, TRX2. , 2011, Molecular cell.

[21]  W. Wilson,et al.  Targeting hypoxia in cancer therapy , 2011, Nature Reviews Cancer.

[22]  Erika Pastrana,et al.  Eyes wide open: a critical review of sphere-formation as an assay for stem cells. , 2011, Cell stem cell.

[23]  A. Capobianco,et al.  Notch signalling in solid tumours: a little bit of everything but not all the time , 2011, Nature Reviews Cancer.

[24]  J. Arribas,et al.  ADAM17 (TACE) regulates TGFβ signaling through the cleavage of vasorin , 2011, Oncogene.

[25]  R. McLendon,et al.  Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3. , 2011, Cancer cell.

[26]  C. Eberhart,et al.  Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. , 2010, The American journal of pathology.

[27]  R. Fisher,et al.  Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  R. Wilson,et al.  Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.

[29]  M. Wolter,et al.  A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha. , 2010, Brain : a journal of neurology.

[30]  A. Oza,et al.  Phase 1 Study of Tirapazamine in Combination With Radiation and Weekly Cisplatin in Patients With Locally Advanced Cervical Cancer , 2010, International Journal of Gynecologic Cancer.

[31]  C. Brennan,et al.  Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. , 2010, Cell stem cell.

[32]  B. Sullenger,et al.  Notch Promotes Radioresistance of Glioma Stem Cells , 2009, Stem cells.

[33]  Guido Nikkhah,et al.  NOTCH Pathway Blockade Depletes CD133‐Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts , 2009, Stem cells.

[34]  J. Uhm,et al.  The transcriptional network for mesenchymal transformation of brain tumours , 2010 .

[35]  D. Zelterman,et al.  Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity. , 2009, Cancer research.

[36]  J. Engh,et al.  Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α , 2009, Oncogene.

[37]  J. Kaanders,et al.  Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia. , 2009, European journal of cancer.

[38]  B. Cochran,et al.  STAT3 Is Required for Proliferation and Maintenance of Multipotency in Glioblastoma Stem Cells , 2009, Stem cells.

[39]  G. Weinmaster,et al.  Numb Regulates Post-endocytic Trafficking and Degradation of Notch1* , 2009, The Journal of Biological Chemistry.

[40]  Hui Wang,et al.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. , 2009, Cancer cell.

[41]  H. Fine,et al.  SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. , 2009, Cell stem cell.

[42]  Tatsuya Ozawa,et al.  PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. , 2009, Cell stem cell.

[43]  S. Williamson,et al.  Tirapazamine: a novel agent targeting hypoxic tumor cells. , 2009, Expert opinion on investigational drugs.

[44]  N. Denko,et al.  Hypoxia, HIF1 and glucose metabolism in the solid tumour , 2008, Nature Reviews Cancer.

[45]  Q. Su,et al.  Notch-1 regulates transcription of the epidermal growth factor receptor through p53. , 2008, Carcinogenesis.

[46]  E. Rankin,et al.  The role of hypoxia-inducible factors in tumorigenesis , 2008, Cell Death and Differentiation.

[47]  U. Lendahl,et al.  Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways , 2008, Proceedings of the National Academy of Sciences.

[48]  Guang-hui Li,et al.  STAT3 silencing with lentivirus inhibits growth and induces apoptosis and differentiation of U251 cells , 2008, Journal of Neuro-Oncology.

[49]  Brian Keith,et al.  Hypoxia-Inducible Factors, Stem Cells, and Cancer , 2007, Cell.

[50]  Mark W. Dewhirst,et al.  Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment , 2007, Cancer and Metastasis Reviews.

[51]  P. Ratcliffe,et al.  Target gene selectivity of hypoxia-inducible factor-α in renal cancer cells is conveyed by post-DNA-binding mechanisms , 2007, British Journal of Cancer.

[52]  I. Bayazitov,et al.  A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.

[53]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[54]  Arvind P Pathak,et al.  Characterizing vascular parameters in hypoxic regions: a combined magnetic resonance and optical imaging study of a human prostate cancer model. , 2006, Cancer research.

[55]  S. Bray.  Notch signalling: a simple pathway becomes complex , 2006, Nature Reviews Molecular Cell Biology.

[56]  J. Aster,et al.  A phase I clinical trial of the notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and other leukemias. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  L. Miele.  Notch signaling. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

[58]  J. Crowley,et al.  Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer: Southwest Oncology Group Trial S0003. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  U. Lendahl,et al.  Hypoxia requires notch signaling to maintain the undifferentiated cell state. , 2005, Developmental cell.

[60]  F. Schweisguth,et al.  The roles of receptor and ligand endocytosis in regulating Notch signaling , 2005, Development.

[61]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[62]  Yoshihiro Morikawa,et al.  Vasorin, a transforming growth factor beta-binding protein expressed in vascular smooth muscle cells, modulates the arterial response to injury in vivo. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[63]  J. Brown,et al.  Exploiting tumour hypoxia in cancer treatment , 2004, Nature Reviews Cancer.

[64]  M. Dewhirst,et al.  Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. , 2004, Cancer cell.

[65]  G. Semenza.  Intratumoral hypoxia, radiation resistance, and HIF-1. , 2004, Cancer cell.

[66]  Brian Keith,et al.  Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation , 2003, Molecular and Cellular Biology.

[67]  C. McGlade,et al.  Mammalian Numb Proteins Promote Notch1 Receptor Ubiquitination and Degradation of the Notch1 Intracellular Domain* , 2003, Journal of Biological Chemistry.

[68]  Brian Keith,et al.  Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. , 2003, Molecular and cellular biology.

[69]  Adrian L. Harris,et al.  Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.

[70]  P. Pelicci,et al.  Numb Is an Endocytic Protein , 2000, The Journal of cell biology.

[71]  David J. Anderson,et al.  Culture in Reduced Levels of Oxygen Promotes Clonogenic Sympathoadrenal Differentiation by Isolated Neural Crest Stem Cells , 2000, The Journal of Neuroscience.

[72]  Nadine Kabbani,et al.  Enhanced Proliferation, Survival, and Dopaminergic Differentiation of CNS Precursors in Lowered Oxygen , 2000, The Journal of Neuroscience.

[73]  J. Grubb,et al.  Chloroquine inhibits lysosomal enzyme pinocytosis and enhances lysosomal enzyme secretion by impairing receptor recycling , 1980, The Journal of cell biology.